Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aichi Medical School
Follicular thyroid carcinoma distinguished from adenoma
July 6th, 2005
Follicular thyroid carcinoma could be distinguished from adenoma by reverse transcription-polymerase chain reaction (RT-PCR). According to a study from Japan, "We prospectively tested whether circulating tumor cells could be detected in peripheral blood of patients with thyroid tumors by a RT-PCR to detect carcinoembryonic antigen (CEA) messenger RNA (mRNA). We assayed for CEA mRNA by RT-PCR in peripheral blood sampled before and 2 to 3 weeks after curative surgery for thyroid tumors in 121 patients." "Blood samples from 7 patients with chronic thyroiditis and 7 healthy subjects served as controls. No control samples were positive for CEA mRNA by...
Source: Biotech Week (2005-07-06)
|
